Affimed Announces Annual General Meeting of Shareholders
05 June 2019 - 6:01AM
Heidelberg, Germany, June 04, 2019 – Affimed
N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company
committed to giving patients back their innate ability to fight
cancers, announced today that the Annual General Meeting of
Shareholders will be held on Tuesday, June 25, 2019. The meeting
will be held at NH Collection Amsterdam Grand Hotel Krasnapolsky,
Dam 9, 1012 JS Amsterdam, the Netherlands. The meeting will start
at 3:00 p.m. CET.
The notice and agenda of the general meeting are
available free of charge in the Investor Relations section under
“Notice to convene Annual General Meeting of Shareholders of
Affimed N.V.” of Affimed’s corporate website at
https://www.affimed.com/investors/. They are also available on the
SEC’s website at www.sec.gov.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical stage
biopharmaceutical company committed to giving patients back their
innate ability to fight cancer. Affimed’s fit-for-purpose ROCK®
platform allows innate cell engagers to be designed for specific
patient populations. The Company is developing single and
combination therapies to treat cancers. For more information,
please visit www.affimed.com.
Affimed Investor
Contact:Gregory Gin, Head of Investor RelationsE-Mail:
IR@affimed.com
Affimed Media Contact:Anca
Alexandru, Head of Communications, EU IRE-Mail:
media@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2024 to May 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From May 2023 to May 2024